0000899243-20-021902.txt : 20200810
0000899243-20-021902.hdr.sgml : 20200810
20200810180145
ACCESSION NUMBER: 0000899243-20-021902
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200806
FILED AS OF DATE: 20200810
DATE AS OF CHANGE: 20200810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chaudhary Kleem
CENTRAL INDEX KEY: 0001817587
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39425
FILM NUMBER: 201090582
MAIL ADDRESS:
STREET 1: C/O CHECKMATE PHARMACEUTICALS, INC.
STREET 2: 245 MAIN STREET, 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Checkmate Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001651431
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 364813934
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 MAIN STREET, 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 978-503-2124
MAIL ADDRESS:
STREET 1: 245 MAIN STREET, 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-06
0
0001651431
Checkmate Pharmaceuticals, Inc.
CMPI
0001817587
Chaudhary Kleem
C/O CHECKMATE PHARMACEUTICALS, INC.
245 MAIN STREET, 2ND FLOOR
CAMBRIDGE
MA
02142
0
1
0
0
Chief Business Officer
Stock Option (Right to Buy
15.00
2020-08-06
4
A
0
141226
0.00
A
2030-08-05
Common Stock
141226
141226
D
25% of the shares subject to such option vest and become exercisable on August 6, 2021 and the remainder of the shares vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
/s/ Kleem Chaudhary
2020-08-10